Supreme Court Questions Centre on Medicine Pricing and Regulatory Oversight
The Supreme Court questioned the Centre over the significant gap between the maximum retail price (MRP) of medicines and the prices retailers pay, highlighting concerns that the system favors pharmaceutical manufacturers. The court criticized the National Pharmaceutical Pricing Authority (NPPA) as ineffective and questioned the government's policy of not controlling the entire ecosystem. While the Centre defended India's relatively low medicine prices and cited a recent cap on anti-cancer drug margins, the court reserved its order, emphasizing the need for greater price regulation and affordability for patients.
First-hand measurement across 13 sources
We measured how 13 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (29/100). Lens Score 63/100.
Outlets measured: businessstandard, deccanherald, mint, hindustantimes, news18, moneycontrol, httpswwwoutlookindiacom, thetelegraph, and 5 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–32/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 27 Oct, 10:15 am. Other outlets followed.